Intervention

Right Heart Catheterization

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting1

Common conditions9

Lead sponsors shown6

Clinical trials

6 shown

Electrical Impedance Tomography for Assessment of Pulmonary HypertensionNCT07453017 · 2024-04-26

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart FailureNCT05672719 · 2021-10-19

Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)NCT04008550 · 2019-03-06

Genetic and Environmental Determinants That Control Metabolism in Pulmonary HypertensionNCT02594917 · 2015-10-01

Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking AnorecticsNCT01185730 · 2011-01-01

Natrecor in Pulmonary HypertensionNCT00075179 · 2003-12-31

Common conditions

Pulmonary Hypertension5 Aortic Valve Stenosis1 Cancer1 Cardiothoracic Surgery1 Friedreich Ataxia1 Heart Failure1 Iron-sulfur Cluster Deficiency1 Lung Disease1 Pulmonary Thromboembolisms1

Leading sponsors

Assistance Publique - Hôpitaux de Paris1 M.D. Anderson Cancer Center1 Mount Sinai Hospital, Canada1 University Hospital, Rouen1 University of Pittsburgh1 University of Sao Paulo General Hospital1

Trial status mix

COMPLETED2

TERMINATED2

RECRUITING1

UNKNOWN1

Phase mix

NA3

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.